Secret HIV Funding Decisions Locked Behind Closed Doors
Published Date: 3/19/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting from April 30 to May 1, 2025, to review secret grant applications focused on fighting HIV. This meeting affects researchers applying for funding and keeps sensitive info private. No public access or money changes are announced, but important decisions on grant awards will be made.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Applicant Confidentiality Protected
The meeting will review R01 and R21 (Clinical Trial Not Allowed) grant applications on strategies for eliminating HIV proteins on April 30–May 1, 2025, and the discussions may disclose confidential trade secrets, patentable material, and personal information. Those applicant materials and discussions will be kept private to protect commercial secrets and personal privacy.
Meeting Closed to the Public
The National Institute of Allergy and Infectious Diseases will hold a meeting that is closed to the public on April 30–May 1, 2025 (10:00 a.m. to 6:00 p.m.). The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6), so members of the public cannot attend the grant review discussions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in